GREENSBORO, N.C. – The release of one of the most widely anticipated pesticides in years got one step closer to happening when Syngenta agreed to pay Bayer $120 million to settle Bayer’s patent infringement suit surrounding Syngenta’s new chemistry, thiamethoxam.
The chemical, which will serve as the active ingredient in Syngenta’s yet-to-be released insecticide Meridian, is part of the neonicotinoid class of products. Bayer filed the suit on the basis that the product violated patents awarded to its leading insecticide called imidacloprid, which is marketed to lawn care professionals as the popular grub control product Merit. In addition, Syngenta will market products containing thiamethoxam into the agricultural crop and seed treatment markets.
Syngenta’s motivation in reaching such a deal with Bayer is obvious – the company expects thiamethoxam-based products to exceed $200 million.
Latest from Lawn & Landscape
- Caterpillar's Umpleby III to retire as executive chairman of board
- Breaking down the HighGrove Partners sale to Agellus Capital
- Registration open for the Lawn & Landscape Technology Conference
- OTR Engineered Solutions names Oscar Torres president, CEO
- The rules of M&A are changing
- Our top stories of 2025
- Exscape Group adds 3
- Alpine Gardens earns NALP, ALCC awards for Estes Park project
